Chaim Lebovits
CIK: 0001406302
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BRAINSTORM CELL THERAPEUTICS INC.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Feb 26, 2026BCLI
BRAINSTORM CELL THERAPEUTICS INC.
Award(A)Direct1.8M shares- - Jan 1, 2025BCLI
BRAINSTORM CELL THERAPEUTICS INC.
Award(A)Direct120K shares- - Oct 1, 2024BCLI
BRAINSTORM CELL THERAPEUTICS INC.
Purchase(P)Direct1.8K shares at avg. $3.43$6K - Sep 30, 2024BCLI
BRAINSTORM CELL THERAPEUTICS INC.
Purchase(P)Direct22K shares at avg. $0.23$5K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 26, 2026 | BCLI BRAINSTORM CELL THERAPEUTICS INC. | Award(A) | 1,800,000 | - | $0 | Direct |
| Jan 1, 2025 | BCLI BRAINSTORM CELL THERAPEUTICS INC. | Award(A) | 120,000 | - | $0 | Direct |
| Oct 1, 2024 | BCLI BRAINSTORM CELL THERAPEUTICS INC. | Purchase(P) | 1,836 | $3.43 | $6,292 | Direct |
| Sep 30, 2024 | BCLI BRAINSTORM CELL THERAPEUTICS INC. | Purchase(P) | 22,000 | $0.23 | $5,016 | Direct |
1-4 of 4 transactions
About Lebovits Chaim
Lebovits Chaim (SEC CIK 0001406302) files insider reports with the SEC as President & CEO of BRAINSTORM CELL THERAPEUTICS INC. (BCLI).
Signal8 holds 3 ownership filings by Lebovits Chaim, all Form 4s, filed between Oct 2, 2024 and May 29, 2026. Those filings report 4 transactions, from Sep 30, 2024 to Feb 26, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Lebovits Chaim's filings is in NEW YORK, NY.
Recent filings by Lebovits Chaim
Other insiders filing for BRAINSTORM CELL THERAPEUTICS INC. (BCLI)
- FRENKEL JACOB A, Director
- Pitts Peter Joe, Executive Chairman
- Yablonka Uri, EVP & Chief Business Officer
- Patlis Alla
- ARBEL IRIT, Director
- Bairu Menghisteab, Director